BusinessFair Access Medicines Appoints Dr. Hunter Gillies as Chief Medical OfficerBy Nasdaq OMXDec 7, 2017, 7:47 PM UTC
BusinessThermalin Announces: Collaboration with Sanofi to Develop Next Generation Insulin TherapiesBy Nasdaq OMXSep 28, 2017, 2:39 PM UTC
BusinessXOMA Announces Significant Step Toward Initiating Pediatric Phase 2 Clinical Study for XOMA 358 in Children with Congenital HyperinsulinismBy Nasdaq OMXOct 19, 2016, 1:01 PM UTC
BusinessXOMA Provides Update from Ongoing Phase 2 XOMA 358 Clinical StudiesBy Nasdaq OMXSep 15, 2016, 11:26 PM UTC
